Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
نویسندگان
چکیده
منابع مشابه
Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
PURPOSE This open-label study assessed the safety and immunogenicity of two doses and two routes of the anti-idiotypic monoclonal antibody abagovomab (formerly ACA125) in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. EXPERIMENTAL DESIGN Eligible patients from the three participating institutions were any stage at diagnosis, had relapsed, and had complete or p...
متن کاملEpothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
Ovarian cancer is the most lethal gynecologic malignancy; consequently, there is a need for effective therapies. Epothilones are microtubule-stabilizing agents that inhibit cell growth. Currently, patupilone and its four synthetic derivatives ixabepilone, BMS-310705, sagopilone, 20-desmethyl-20-methylsulfanyl epothilone B and epothilone D, as well as its derivative KOS-1584, are under clinical ...
متن کاملPrimary Fallopian Tube Cancer: An Unusual Case of Inguinal Lymphadenopathy
Background: Primary fallopian tube cancers (PFTCs) are rare gynecological malignancies by the prevalence of 0.3-1%. The PFTCs occur in individuals within the age range of 18-88 years, more specifically at the age range of 40-65 years with the mean age of 55 years. The PFTC usually is observed with the chronic inflammation of the fallopian tube, infertility, tuberculous salpingi...
متن کاملFallopian Tube Carcinoma: A Case Report and Review of Litrature
Primary fallopian tube carcinoma is a rare tumor that histologically and clinically resembles epithelial ovarian cancer. Here we introduce a case of tubal carcinoma in a postmenopausal woman. The diagnosis of primary fallopian tube carcinoma is rarely considered preoperatively and is usually first appreciated by the pathologist. Because of low frequency of tubal carcinoma, there are few systemi...
متن کاملBevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
OBJECTIVE Bevacizumab was recently approved by the US Food and Drug Administration for use in recurrent platinum resistant epithelial ovarian cancer (EOC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) when no more than two prior cytotoxic regimens have been used; due to concerns for gastrointestinal perforation. We sought to determine bevacizumab-related toxicities in heavily...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Cancer
سال: 2018
ISSN: 1471-2407
DOI: 10.1186/s12885-018-4700-3